A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease
Abstract Introduction Acute exacerbation (AE) is a devastating phenomenon and reported to be complicated with systemic autoimmune disease-associated interstitial lung disease (ILD). The aim of this study was to investigate the incidence and prognosis of AE of systemic autoimmune disease-ILD and clar...
Main Authors: | Hiroyuki Kamiya, Ogee Mer Panlaqui |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12890-021-01502-w |
Similar Items
-
Three cases of sequential treatment with nintedanib following pulsed-dose corticosteroids for acute exacerbation of interstitial lung diseases
by: Kazuki Nakashima, et al.
Published: (2021-01-01) -
Acute Exacerbation in Interstitial Lung Disease
by: Gabriela Leuschner, et al.
Published: (2017-10-01) -
Glasgow prognostic score for prediction of chemotherapy‐triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer
by: Ryota Kikuchi, et al.
Published: (2021-06-01) -
The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation
by: Belén Atienza-Mateo, et al.
Published: (2020-05-01) -
Glasgow Prognostic Score predicts chemotherapy‐triggered acute exacerbation‐interstitial lung disease in patients with non‐small cell lung cancer
by: Ryota Kikuchi, et al.
Published: (2021-03-01)